Stay updated on Safety of ZX008 in Dravet/Lennox Gastaut Children Clinical Trial
Sign up to get notified when there's something new on the Safety of ZX008 in Dravet/Lennox Gastaut Children Clinical Trial page.

Latest updates to the Safety of ZX008 in Dravet/Lennox Gastaut Children Clinical Trial page
- Check5 days agoChange DetectedThe page footer now shows Revision: v3.5.4, replacing v3.5.3. This reflects a minor template update and does not modify the study information presented on the page.SummaryDifference0.2%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check27 days agoChange DetectedThe page revision marker was updated from v3.5.2 to v3.5.3, reflecting a site/version update without changing the study information presented.SummaryDifference0.1%

- Check34 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.2%

- Check48 days agoChange DetectedAdded a related topic term, Severe myoclonic epilepsy in infancy, to the page's topics section.SummaryDifference0.2%

- Check55 days agoChange DetectedDravet syndrome was removed from the conditions list on the study page, along with related references to that condition.SummaryDifference0.1%

- Check63 days agoChange DetectedRevision: v3.5.0 is now displayed, replacing Revision: v3.4.3.SummaryDifference0.2%

Stay in the know with updates to Safety of ZX008 in Dravet/Lennox Gastaut Children Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of ZX008 in Dravet/Lennox Gastaut Children Clinical Trial page.